Summary
The Breast-Diagnosis collection contains cases that are high-risk normals, DCIS, fibroids and lobular carcinomas. Each case has 3 or more distinct MR pulse sequences from a Phillips 1.5 T (usual sequences are labeled T2, STIR and BLISS but may occasionally include other pulse sequences and digital mammogram of tumor specimen). Multiple time point studies on the same patient are possible.
The following is relevant to analyzing the contrast dynamics of the BLISS pulse sequences. The pulse sequence parameters (repetition, echo time, etc.) can be extracted from the DICOM tags. The contrast aspects are as follows: The volume of Magnevist (Bayer) gadolinium contrast injected into the brachial vein is based on a rule of thumb which in ml's is 10% of the patient wright in POUNDS (NOT Kilograms as is recorded in the DICOM patient weight tag. Hence the injected volume for a 150 lb patient is 15 ml. (the DICOM tag entry on that patient will read "68"). The injection itself is 6 or 7 seconds, at a rate of 3cc per second. The first dynamic sequence is started 1 minute after the injection is started. Slice and pulse parameters are accessible in the DICOM tags.
For scientific inquiries relating to this data set please contact Dr. Carl Jaffe at:
- carl.jaffe@bmc.org
Data Access
Imaging Data
You can view and download these images on The Cancer Imaging Archive by logging in to TCIA and selecting the Breast-Diagnosis collection.
Collection Statistics |
|
|---|---|
Modalities |
MR (with some PET/CT) |
Number of Patients |
88 |
Number of Studies |
148 |
Number of Series |
429 |
Number of Images |
105,050 |
If you are unsure how to download this Collection please view our quick guide on Searching by Collection or refer to our The Cancer Imaging Archive User's Guide for more detailed instructions on using the site.
Metadata
This collection includes a spreadsheet (updated 7/16/11) with BIRADS MRI features from the imaging report and denoted key image slice with the approximate X-Y center position if a mass was found. Key clinical features and abstracts of the pathology report including ER, PR and HER2 results and Oncotype score are included when available.